8-K - Tyra Biosciences, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Tyra Biosciences designated Julia Rueb as principal accounting officer, succeeding CFO Alan Fuhrman in that role, effective April 1, 2026, while Fuhrman remains principal financial officer.

Key Takeaways

1Julia Rueb appointed as principal accounting officer effective April 1, 2026.

2Alan Fuhrman succeeded as principal accounting officer but continues as principal financial officer.

3Rueb has served as Vice President, Finance since January 2024 with prior accounting roles at SOAProjects and Ernst & Young.

4Rueb holds a Master's in Accounting from University of San Diego and is a Certified Public Accountant.

5No family relationships exist between Rueb and the company's directors or executive officers.

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 1, 2

Management Change

Executive & Director Changes

Julia Rueb

principal accounting officer

designated

Effective: 2026-04-01

succeeding Alan Fuhrman in that role

Alan Fuhrman

principal accounting officer

succeeded

Effective: 2026-04-01

Exhibits (1)

8-K